title: Primary intraocular lymphoma in a patient with systemic lupus erythematosus.
authors.forename: Feng Jung S H
authors.initials: FJ
authors.lastname: Woei-A-Jin
authors.forename: Sabina
authors.initials: S
authors.lastname: Kersting
authors.forename: Jan Geert
authors.initials: JG
authors.lastname: Bollemeijer
mesh_terms: D003937:Diagnosis, Differential; D015817:Eye Infections / Q000175:diagnosis; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016753:Interleukin-10 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology; D008223:Lymphoma / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D008266:Macula Lutea / Q000276:immunology / Q000473:pathology; D008875:Middle Aged; D009894:Opportunistic Infections / Q000175:diagnosis; D015864:Panuveitis / Q000209:etiology; D019572:Retinal Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D015354:Vision, Low / Q000209:etiology; D014821:Vitrectomy; D014822:Vitreous Body / Q000276:immunology / Q000378:metabolism / Q000473:pathology
chemical_list: C508609:IL10 protein, human; C508600:IL6 protein, human; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D016753:Interleukin-10